Related Experiment Video
Updated: Jun 12, 2025
In Vitro Tumor Cell Rechallenge For Predictive Evaluation of Chimeric Antigen Receptor T Cell Antitumor Function
Published on: February 27, 2019
CD8α Structural Domains Enhance GUCY2C CAR-T Cell Efficacy
Trevor R Baybutt1, Ariana A Entezari1, Adi Caspi1
1Department of Pharmacology, Physiology, and Cancer Biology, Sidney Kimmel Medical College, Thomas Jefferson University, Philadelphia, PA, USA.
Abstract:
Despite success in treating some hematological malignancies, CAR-T cells have not yet produced similar outcomes in solid tumors due, in part, to the tumor microenvironment, poor persistence, and a paucity of suitable target antigens. Importantly, the impact of the CAR components on these challenges remains focused on the intracellular signaling and antigen-binding domains. In contrast, the flexible hinge and transmembrane domains have been commoditized and are the least studied components of the CAR. Here, we compared the hinge and transmembrane domains derived from either the CD8ɑ or CD28 molecule in identical GUCY2C-targeted third-generation designs for colorectal cancer. While these structural domains do not contribute to differences in antigen-independent contexts, such as CAR expression and differentiation and exhaustion phenotypes, the CD8ɑ structural domain CAR has a greater affinity for GUCY2C. This results in increased production of inflammatory cytokines and granzyme B, improved cytolytic effector function with low antigen-expressing tumor cells, and robust anti-tumor efficacy in vivo compared with the CD28 structural domain CAR. This suggests that CD8α structural domains should be considered in the design of all CARs for the generation of high-affinity CARs and optimally effective CAR-T cells in solid tumor immunotherapy.
Insights
The CD8ɑ hinge and transmembrane domains enhance CAR-T cell affinity for GUCY2C, improving anti-tumor efficacy against colorectal cancer, particularly in low-antigen tumors.
Area of Science:
- Immunology
- Cancer Biology
- Biotechnology
Background:
- CAR-T cell therapy shows promise for hematological malignancies but faces challenges in solid tumors.
- Tumor microenvironment, poor persistence, and antigen scarcity limit CAR-T efficacy in solid tumors.
- CAR components, particularly hinge and transmembrane domains, are understudied regarding their impact on CAR-T cell function.
Purpose of the Study:
- To compare the impact of CD8ɑ- and CD28-derived hinge and transmembrane domains in GUCY2C-targeted CAR-T cells for colorectal cancer.
- To investigate how structural CAR components influence CAR-T cell affinity, effector function, and in vivo anti-tumor efficacy.
Main Methods:
- Designed third-generation CAR-T cells targeting GUCY2C with either CD8ɑ or CD28 hinge and transmembrane domains.
- Assessed CAR expression, differentiation, exhaustion phenotypes, GUCY2C binding affinity, cytokine production, and cytolytic activity.
- Evaluated in vivo anti-tumor efficacy in a colorectal cancer model.
Main Results:
- CD8ɑ and CD28 domains did not affect CAR expression or T cell phenotypes in antigen-independent contexts.
- CAR-T cells with CD8ɑ structural domains exhibited higher affinity for GUCY2C.
- Enhanced production of inflammatory cytokines and granzyme B, improved cytolytic function against low-antigen tumors, and robust in vivo anti-tumor activity were observed with CD8ɑ CARs.
Conclusions:
- CD8ɑ hinge and transmembrane domains can enhance CAR-T cell affinity and effector functions.
- These structural components are critical for optimizing CAR-T cell therapy in solid tumors like colorectal cancer.
- Consideration of CD8ɑ structural domains in CAR design may lead to more effective CAR-T cell therapies for solid tumors.
Related Concept Videos
01:22T Cell Activation and Clonal Selection
Naive T cells that have not yet encountered an antigen express two primary CD...
01:27Cytotoxic T Cells-mediated Immune Response
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
01:31Immunoglobulin-like Cell Adhesion Molecules
Ig-CAMs exhibit either homophilic binding (to other Ig-CAMs) or heterophilic binding (to other ligands such as integrins). While most Ig-CAMs...
01:40Cell-mediated Immune Responses
01:24B Cell Activation and Differentiation
When naive B cells encounter a specific antigen that can bind to the B cell receptor (BCR) on their surface, they undergo sensitization to respond to the antigen's presence. Sensitization begins with...
01:22Antigen Presenting Cells
T cells require the help of antigen-presenting cells (APCs), which process foreign antigens into smaller fragments that can be recognized by T cells. These APCs are highly specialized cells that efficiently internalize antigens...